A case of Fabry disease with central nervous system (CNS) demyelinating lesions: a double trouble?

被引:11
作者
Invernizzi, P. [1 ]
Bonometti, M. A. [1 ]
Turri, E. [1 ]
Benedetti, M. D. [1 ]
Salviati, A. [1 ]
机构
[1] Univ Verona, Policlin GB Rossi, Neurol Clin, Dept Neurol Sci & Vis,Sect Clin Neurol, I-37100 Verona, Italy
关键词
evoked potentials; Fabry disease; magnetic resonance imaging; multiple sclerosis; oligoclonal bands; white matter lesions;
D O I
10.1177/1352458508092355
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We present the case of a 36-year-old woman affected with Fabry disease (FD), with neuroradiologic and laboratory tests suggestive of a coexistent inflammatory demyelinating disease. Since the age of 23, she presented recurrent neurologic deficits, such as right limb paresthesias, diplopia, and right leg weakness. Magnetic resonance imaging revealed multiple demyelinating lesions in periventricular areas, corpus callosum, and spinal cord. Cerebrospinal fluid analysis showed the presence of oligoclonal bands, while visual-evoked potentials were delayed with preserved morphology. FD is usually considered as a differential diagnosis of multiple sclerosis, but we think that the best explanation of all pathological features in this case is the coexistence of the two diseases.
引用
收藏
页码:1003 / 1006
页数:4
相关论文
共 15 条
[1]  
Arias Martinez N, 2003, An Med Interna, V20, P28
[2]  
Callegaro D, 2006, Int MS J, V13, P27
[3]   Natural history of Fabry disease in females in the Fabry outcome survey [J].
Deegan, PB ;
Baehner, AF ;
Romero, MAB ;
Hughes, DA ;
Kampmann, C ;
Beck, M .
JOURNAL OF MEDICAL GENETICS, 2006, 43 (04) :347-352
[4]   Fabry disease, an under-recognized multisystemic disorder: Expert recommendations for diagnosis, management, and enzyme replacement therapy [J].
Desnick, RJ ;
Brady, R ;
Barranger, J ;
Collins, AJ ;
Germain, DP ;
Goldman, M ;
Grabowski, G ;
Packman, S ;
Wilcox, WR .
ANNALS OF INTERNAL MEDICINE, 2003, 138 (04) :338-346
[5]   Safety and efficacy of recombinant human α-galactosidase a replacement therapy in Fabry's disease. [J].
Eng, CM ;
Guffon, N ;
Wilcox, WR ;
Germain, DP ;
Lee, P ;
Waldek, S ;
Caplan, L ;
Linthorst, GE ;
Desnick, RJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (01) :9-16
[6]   White matter lesion severity in male and female patients with Fabry disease [J].
Fellgiebel, A ;
Müller, MJ ;
Mazanek, M ;
Baron, K ;
Beck, M ;
Stoeter, P .
NEUROLOGY, 2005, 65 (04) :600-602
[7]   CNS manifestations of Fabry's disease [J].
Fellgiebel, Andreas ;
Mueller, Matthias J. ;
Ginsberg, Lionel .
LANCET NEUROLOGY, 2006, 5 (09) :791-795
[8]   Fabry disease: a morphologic study of 11 cases [J].
Fischer, Edgar G. ;
Moore, Michael J. ;
Lager, Donna J. .
MODERN PATHOLOGY, 2006, 19 (10) :1295-1301
[9]   Magnetic resonance imaging changes in Fabry disease [J].
Ginsberg, L ;
Manara, R ;
Valentine, AR ;
Kendall, B ;
Burlina, AP .
ACTA PAEDIATRICA, 2006, 95 :57-62
[10]  
LOEB H, 1968, HELV PAEDIATR ACTA, V23, P269